Polymorphisms in CYP1B1 modify the risk of idiopathic male infertility with abnormal semen quality

Clinica Chimica Acta

Volumn 412, Issue 19-20, 2011, Pages 1778-1782

  Hu, Weiyue ^a,b   Yang, Hua ^a,b   Sun, Jie ^a,b   Zhang, Qiuyi ^a,b   Yang, Jingjin ^a,b   Lu, Lu ^a,b   Zhang, Jiacheng ^a,b   Qin, Yufeng ^a,b   Xia, Yankai ^a,b   Wang, Xinru ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

Author keywords

CYP1B1; Idiopathic male infertility; Semen parameters; SNPs

Indexed keywords

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CYP1B1 GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PRIORITY JOURNAL; RISK REDUCTION; SEMEN ABNORMALITY; SEMEN ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPERMATOZOON MOTILITY;

ADULT; ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; HUMANS; INFERTILITY, MALE; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEMEN;

EID: 79960638167     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.037     Document Type: Article

References (19)

1. Huynh T., Mollard R., Trounson A. Selected genetic factors associated with male infertility. Hum Reprod Update 2002, 8:183-198.
2. Skakkebaek N.E., Giwercman A., de Kretser D. Pathogenesis and management of male infertility. Lancet 1994, 343:1473-1479.
3. Multigner L., Ndong J.R., Giusti A., et al. Chlordecone exposure and risk of prostate cancer. J Clin Oncol 2010, 28:3457-3462.
4. Xia Y., Zhu P., Han Y., et al. Urinary metabolites of polycyclic aromatic hydrocarbons in relation to idiopathic male infertility. Hum Reprod 2009, 24:1067-1074.
5. Johansson I., Ingelman-Sundberg M. Genetic polymorphism and toxicology-with emphasis on cytochrome p450. Toxicol Sci 2011, 120:1-13.
6. Agundez J.A. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004, 5:211-224.
7. Hayes C.L., Spink D.C., Spink B.C., et al. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 1996, 93:9776-9781.
8. Newbold R.R., Liehr J.G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000, 60:235-237.
9. Su M.T., Chen C.H., Kuo P.H., et al. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Fertil Steril 2010, 93:141-149.
10. Lee IW, Kuo PH, Su MT et al. Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility. Hum Reprod 2011, in press.
11. Wu B., Lu N.X., Xia Y.K., et al. A frequent Y chromosome b2/b3 subdeletion shows strong association with male infertility in Han-Chinese population. Hum Reprod 2007, 22:1107-1113.
12. Eddy E.M., Washburn T.F., Bunch D.O., et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 1996, 137:4796-4805.
13. Adeoya-Osiguwa S.A., Markoulaki S., Pocock V., et al. 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function. Hum Reprod 2003, 18:100-107.
14. Idaomar M., Guerin J.F., Lornage J., Moncharmont P., Czyba J.C. Effects of estradiol and its antagonist tamoxifen on motility and metabolism of human spermatozoa. Adv Contracept Deliv Syst 1987, 3:337-345.
15. Hanna I.H., Dawling S., Roodi N., et al. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000, 60:3440-3444.
16. Fuortes L., Clark M.K., Kirchner H.L., Smith E.M. Association between female infertility and agricultural work history. Am J Ind Med 1997, 31:445-451.
17. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001, 16:972-978.
18. Ho S.M., Tang W.Y., Belmonte de Frausto J., Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006, 66:5624-5632.
19. Gruber A.R., Lorenz R., Bernhart S.H., et al. The Vienna RNA websuite. Nucleic Acids Res 2008, 36:W70-W74.